| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT07220915 Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent… |
Trial sites expanded: 1 -> 6 locations |
| 2026-07-23 | NCT07220915 Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent… |
Recruitment opened |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05935358 | Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular… | Severe Hemophilia A | Recruiting |
| NCT05936580 | Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing… | Hemophilia A | Recruiting |
| Phase 3 | |||
| NCT06096116 | Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ)… | Acquired Antithrombin Deficiency | Recruiting |
| NCT04918173 | Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing… | Congenital Antithrombin Deficiency | Recruiting |
| NCT04929236 | Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric… | Pediatric Chronic Inflammatory Demyelinating Polyneuropathy | Recruiting |
| NCT06361537 | Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With… | Acute Hereditary Angio Edema | Recruiting |
| NCT07220915 | Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent… | Hypogammaglobulinemia | Recruiting |
| NCT04640142 | Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of… | Primary Immune Deficiency | Active, Not Recruiting |
| Not specified | |||
| NCT03695978 | Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated &… | Haemophilia A | Recruiting |
| NCT06429787 | Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of… | Vitamin K-Dependent Coagulation Defect | Recruiting |
| NCT04106908 | Effectiveness and Tolerability of Eqwilate in Real-life Conditions | VWD - Von Willebrand's Disease | Active, Not Recruiting |